• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Amalgam Rx Secures $20M to Accelerate AI-Powered Healthcare Solutions

by Fred Pennic 08/12/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Amalgam Rx Secures $20M to Accelerate AI-Powered Healthcare Solutions

What You Should Know: 

– Amalgam Rx, a company specializing in data-driven healthcare decision-making, has announced a $20M credit investment from Catalio Capital Management. 

– The $20M senior secured term loan provides Amalgam with an initial draw of $12M to support its market expansion and refinance existing corporate debt. The credit investment also gives Amalgam access to Catalio’s extensive network of life sciences leaders, including its board of advisors and over 45 Catalio Venture Partners. These partners are composed of renowned scientist-entrepreneurs who will provide strategic insights to support product development and commercial growth.

Prioritizing Safety and Integrity in Medical AI

As AI becomes more integrated into healthcare, ensuring its safety, compliance, and integrity is of the utmost importance. Amalgam has spent five years developing its proprietary Medical-Grade AI platform, which is engineered with built-in safeguards to meet rigorous clinical, ethical, and regulatory standards. This technology allows healthcare organizations to safely, quickly, and confidently harness the power of AI. The funding will be used to accelerate the scaling of Amalgam’s Medical-Grade AI solutions, which are designed to empower both patients in their daily lives and providers in their clinical workflows.

Ryan Sysko, CEO of Amalgam Rx, noted that Catalio’s “deep expertise in healthcare and life sciences, combined with their expansive venture network, makes them an ideal partner as we scale”. He stated that the funding will accelerate the development and deployment of the company’s AI platform, ultimately advancing its mission to transform chronic disease management through intelligent, personalized care.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

The AI Paradox in Healthcare: Notable CEO Shares Why Moving Too Slowly is a Greater Risk

Most-Read

Patient Square Capital Acquires Premier in $2.6B Deal

Pfizer Acquires Metsera for $4.9B, Expanding into Obesity and Cardiometabolic Market

Pfizer Acquires Metsera for $4.9B, Expanding into Obesity and Cardiometabolic Market

CVS Health Subsidiary Omnicare Files for Bankruptcy to Tackle Financial Challenges

CVS Health Subsidiary Omnicare Files for Bankruptcy to Tackle Financial Challenges

Sutter Health and Epic Launch "Sutter Sync" to Optimize Remote Chronic Care

Sutter Health and Epic Launch “Sutter Sync” to Optimize Remote Chronic Care

Corti Joins Coalition for Health AI to Advance Responsible and Safe AI in Healthcare

Joint Commission and CHAI Release First-Ever Guidance for Responsible AI in Healthcare

71% of Hospitals Now Use Predictive AI, But a Digital Divide Remains

71% of Hospitals Now Use Predictive AI, But a Digital Divide Remains

PHTI Report: Virtual OUD Solutions are Effective, But Don't Substantially Reduce Costs

PHTI Report: Virtual OUD Solutions are Effective, But Don’t Substantially Reduce Costs

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Oracle Health Launches AI Center of Excellence for Healthcare

Oracle Health Launches AI Center of Excellence for Healthcare

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |